Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 3/20 | 0.36 |
| ▸ | IDO1 | P14902 | 2/20 | 0.35 |
| ▸ | AGXT | P21549 | 2/20 | 0.35 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.35 |
| ▸ | MITF | O75030 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 2/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.35 |
| ▸ | CDC25A | P30304 | 1/20 | 0.34 |
| ▸ | CDC25B | P30305 | 1/20 | 0.34 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3796505 | 0.83 | IDO1 (0.34) | NAAAIDO1AGXTALDH1A1ESR1 | |
| SCHEMBL3799785 | 0.78 | PREP (0.43) | NAAAIDO1AGXTPDE4BGSTP1 | |
| SCHEMBL13191568 | 0.75 | PDE4B (0.48) | IDO1AGXTPDE4BMITFALDH1A1 | |
| SCHEMBL13191514 | 0.75 | PDE4B (0.48) | IDO1AGXTPDE4BMITFALDH1A1 | |
| SCHEMBL3799750 | 0.74 | CRHBP (0.35) | NAAA | |
| SCHEMBL9902946 | 0.73 | RXRA (0.49) | ALDH1A1 | |
| SCHEMBL13170495 | 0.69 | EGFR (0.58) | PDE4BMITFALDH1A1MAPTHTT | |
| SCHEMBL9956595 | 0.68 | POLB (0.32) | ALDH1A1 | |
| SCHEMBL863464 | 0.68 | MAPT (0.35) | MAPTHTT | |
| SCHEMBL20160837 | 0.68 | PDE4B (0.52) | PDE4BMITFALDH1A1MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100222432-A1 | Synthetic Carbon Nanotubes | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION | 2010-09-02 | — | — | US | disclosed |
| WO-2008048227-A2 | SYNTHETIC CARBON NANOTUBES | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2008-04-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222432-A1 | Synthetic Carbon Nanotubes | CYCS, CHN2, TUBA3C | NAAA 3128/4885IDO1 4008/4885AGXT 3526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.